Chimerix (CMRX) Misses Q4 EPS by 8c

Chimerix (NASDAQ: CMRX) reported Q4 EPS of ($0.82), $0.08 worse than the analyst estimate of ($0.74). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $2.86 million.

For earnings history and earnings-related data on Chimerix (CMRX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• Worthington Enterprises raises dividend 5%, adds board member